Ask Indegene Icon

Ask Indegene (Beta)

Online
🧠 Building on our previous conversation...

Hello, how can I help you today?

You may type your question or choose from the options below:

Explore Solutions
Browse Insights
View Case Studies
Read Latest News
Explore Careers
Connect with an Expert
Please enter your full name
Please enter a valid work email
Please enter your message

Thank you!

We'll be in touch. In the meantime, feel free to keep exploring!

#PractitionerLevelConfidence

Indegene
Search Icon
The Missing Link: Why Personalized Medical Communications Still Lag in a Personalized Medicine Era
Home
What we think
Blogs Personalized Medical Communications

The Missing Link: Why Personalized Medical Communications Still Lag in a Personalized Medicine Era

Share this blog

02 Feb 2026

In an age where personalized medicine is rapidly transforming patient care, it’s ironic that medical communications remain largely standardized. While the healthcare ecosystem has embraced precision therapies and data-driven insights, the way scientific information is shared with healthcare professionals (HCPs) still follows a “one-size-fits-all” model.

This paradox was the focus of a recent panel discussion at the Indegene Digital Summit 2025 titled “Why Individualized Medical Communications Still Eludes Us in an Era of Individualized Medicine.” Moderated by Sandeep Gantotti, Associate Vice President at Indegene, the conversation brought together Brooke Patterson, Therapeutic Area Lead for Leukaemia and Lymphoma at Johnson & Johnson Innovative Medicine, and Humberto Fonseca, Director of Global Medical Engagement at Ferring Pharmaceuticals. Together, they explored why individualized medical communication continues to lag behind clinical innovation – and what the Medical Affairs community can do to change that.

Transforming Information Overload Into Precision-Driven, Clinician-Centric Impact

In today’s competitive healthcare environment, clinicians are inundated with information. Between clinical updates, congresses, and digital channels, they must filter an overwhelming amount of data to find what’s relevant. For Medical Affairs teams, this means that success no longer depends on simply disseminating accurate information – it depends on delivering the right message in the right format at the right time.

In the absence of individualization, communication just becomes background noise. We need to provide clear, actionable content that meets the needs of each provider’s practice.
Brooke Patterson
Therapeutic Area Lead, Johnson & Johnson Innovative Medicine

Both Patterson and Fonseca emphasized that impactful medical communication requires more than accurate data; it requires understanding how clinicians work, think, and engage. Timing, context, and emotional resonance determine whether content adds value or fades into the background. Adopting a customer-centric mindset helps ensure that scientific information feels relevant and useful rather than overwhelming.

Ultimately, the ability to cut through this noise with clear, relevant, and timely scientific information is becoming a powerful differentiator. As organizations work to refine their approach, those that can deliver communication shaped by real clinical needs rather than broad standardized messaging will be better positioned to build trust and deepen engagement. In many ways, effective medical communication is not just an operational improvement. It is also an opportunity for Medical Affairs teams to gain a meaningful competitive edge by elevating the quality and impact of every interaction with clinicians.

Navigating Compliance Complexity to Unlock Truly Personalized Medical Communications

While the principle of individualized medical communication is universal, its implementation varies dramatically across regions. Regulatory constraints, compliance standards, and cultural nuances all shape what is possible.

In the U.S., Patterson highlighted that medical teams often struggle with what can and cannot be considered “proactive communication” under FDA guidance. This ambiguity can make organizations overly cautious, limiting the ability to personalize scientific communication.

We must be compliant – that’s our North Star. But it’s also time to expand conversations around how we interpret existing guidance so that we can move toward more individualized approaches.
Brooke Patterson
Therapeutic Area Lead, Johnson & Johnson Innovative Medicine

Fonseca shared that similar challenges exist globally. In Europe, the General Data Protection Regulation (GDPR) provides a strong privacy foundation, but local country codes of conduct add further complexity. “It’s difficult to have a harmonized individualized approach when every market has its own legal framework,” he said. His solution: involve medical governance and legal teams early in the content design process, shifting from “policing at the end” to true co-creation from the start.

Despite regional differences, both experts agreed that progress will depend on aligning regulators, Medical Affairs teams, and compliance functions toward a shared understanding of what responsible individualization looks like.

Meeting Clinicians at the Moment That Matters

When asked where individualization can make the greatest difference, both panelists pointed to the point of care. Clinicians face immense pressure to make quick, evidence-based decisions. In those moments, even small barriers, like irrelevant data or poorly formatted information, can hinder the ability to act efficiently.

For Patterson, this insight comes from firsthand experience: “Point of care is where the need and urgency are the highest. The closer we get to supporting providers in real time, the more meaningful the impact.”

Fonseca added a complementary perspective. He argued that individualization should begin much earlier in the engagement journey, even at the point where clinicians consent to share information or participate in data collection.

When physicians give consent, they should immediately receive something of value in return. Each touchpoint should feel rewarding, not extractive.
Humberto Fonseca
Director of Global Medical Engagement, Ferring Pharmaceuticals

The lesson is clear: meaningful communication is not just about delivering information, it’s about timing, reciprocity, and context. This is where digital fluency and integrated data systems can make a tangible difference, ensuring seamless, two-way communication between the field and the clinical community.

From Intention to Execution: Where the Industry Stands

While Medical Affairs leaders widely recognize the value of individualized medical communication, few organizations have operationalized it effectively. Most are somewhere between scaling intent and embedding behavior.

Fonseca believes that technology has outpaced organizational readiness. “We talk a lot about tools and platforms,” he said, “but the real challenge is mindset. We need both the data access and the digital fluency to act on insights with agility.”

Patterson agreed, noting that while commercial teams have made strides in data-driven engagement, medical affairs cannot simply “lift and shift” those models. Instead, the focus must be on building medical-appropriate capabilities such as data analytics, scientific storytelling, and integrated governance that balance scientific rigor with personalization.

Budgeting also remains a constraint. Many organizations still fund medical communications under traditional models, leaving little room for experimentation with new formats or technologies. Shifting this mindset will require not just advocacy but also evidence of impact, supported by clear metrics that demonstrate the value of individualized approaches.

Designing a Communication Ecosystem That Adapts to Every Clinician, Every Time

If all barriers could be overcome, what would success look like?

For Patterson, the vision is simple but powerful: “Right information, right provider, right time.” She imagines a future where every clinician, whether in a large urban hospital or a rural clinic, can instantly access the data they need without having to search for it.

Fonseca envisions a broader system-level change. He believes individualized medical communication should extend beyond clinicians to patients, linking real-world outcomes with clinical development. “If we could feed patient experience data back into clinical research, we’d create value across all stakeholders—patients, physicians, and payers alike,” he said.

This vision of “precision communication” mirrors the goals of precision medicine, delivering information that is both evidence-based and deeply contextualized to the recipient’s needs.

Building the Capabilities for Precision Communication

Realizing that vision will require new competencies across Medical Affairs teams. Beyond digital fluency, Fonseca emphasized two critical skills: data-driven thinking and scientific storytelling.

Medical Affairs teams need to become more data-driven and better at storytelling, translating insights into compelling narratives that resonate across functions.
Humberto Fonseca
Director of Global Medical Engagement, Ferring Pharmaceuticals

Patterson added that fostering an innovation mindset is equally important. “We have to be willing to question how things have always been done,” she said. “That’s not always natural for the medical community, but it’s something we can learn and cultivate.”

Soft skills such as cross-functional collaboration, influencing without authority, and business fluency, will also be key enablers as medical affairs evolves into a more strategic and connected function.

The Role of AI: From Segmentation to True Personalization

Artificial intelligence (AI) has the potential to accelerate this evolution. AI-powered systems can analyze behavioral patterns, preferences, and interaction histories to recommend the most relevant scientific content, similar to how Spotify or Netflix tailor recommendations

Fonseca cautioned, however, that many early tools stop at segmentation rather than achieving true personalization. “Early AI-enabled content tools are promising,” he said, “but we must move beyond segmentation to genuine individualization by delivering the right content through the right channel at the right time.”

Patterson shared a similar optimism, imagining a future where medical content platforms dynamically adapt to each user. “If you watch one video about a topic, the system should learn and recommend more on that area, but also evolve as your interests change,” she said. “The closer we get to that kind of agility, the more we can ensure equitable access to good data for every provider.”

Redefining Medical Communications Through Trust, Relevance, and Continuous Innovation

The discussion closed with a sense of cautious optimism. Both speakers agreed that transformation is already in motion, supported by modular content, agile review processes, and stronger cross-functional partnerships. Yet, lasting change will take time, patience, and consistent effort across medical organizations.

True innovation in medical communication requires more than new technology or processes. It calls for a customer-centric mindset of continuous learning, collaboration, and willingness to evolve. As medicine becomes increasingly individualized, medical communications must follow the same path – advancing toward precision communication that is relevant, responsive, and rooted in trust.

Get exclusive pharma
insights delivered to your inbox

Latest

Let's Partner to Commercialize with Confidence

Powered by Onetrust